Phase II study evaluating efficacy and safety of peripheral blood stem cell harvest with bortezomib for multiple myeloma
Not Applicable
- Conditions
- Multiple Myeloma
- Registration Number
- JPRN-UMIN000010258
- Lead Sponsor
- Fourth Department of Internal Medicine, Sapporo Medical University, School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients HIV-HBs-and HCV-positive. 2) Severe hepatic dysfunction, severe renal failure, severe cardiac dysfunction, severe pulmonary dysfunction, uncontrolled diabetes, uncontrolled hypertension, and uncontrolled infection. 3) Patients with a history of active malignancy. 4) Patients with severe psychiatric disorders. 5) Patients with pregnancy or lactation. 6) Those who are considered as inappropriate to register by attending physicians.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method